{"entity":{"type":"insider","cik":"0001938709","url":"/insider/0001938709","json_url":"/insider/0001938709.json","name":"Casdin Partners FO1-MSV, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":10,"first":"2023-05-19","last":"2024-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Casdin Partners FO1-MSV, LP","source":"filing","n_filings":10,"first_seen":"2023-05-19","last_seen":"2024-06-05"}],"transactions":[{"id":2671928,"accession":"0000919574-24-003510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-003510","line_url":"/filing/0000919574-24-003510#line-2","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":22.5159,"price_display":"22.52","price_state":"stated","total_value":675477.0,"total_display":"675,477.00","total_whole":"675,477","shares_owned_after":3093509.0,"shares_owned_after_display":"3,093,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-05","scope":"insider"},{"id":2671925,"accession":"0000919574-24-003510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003510","line_url":"/filing/0000919574-24-003510#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":20.8164,"price_display":"20.82","price_state":"stated","total_value":2081640.0,"total_display":"2,081,640.00","total_whole":"2,081,640","shares_owned_after":3063509.0,"shares_owned_after_display":"3,063,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2885063,"accession":"0000919574-24-003432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003432","line_url":"/filing/0000919574-24-003432#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Eli; Casdin Partners FO1-MSV, LP; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":21.0651,"price_display":"21.07","price_state":"stated","total_value":842604.0,"total_display":"842,604.00","total_whole":"842,604","shares_owned_after":2963509.0,"shares_owned_after_display":"2,963,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-31","scope":"insider"},{"id":2500607,"accession":"0000919574-24-003355","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-003355","line_url":"/filing/0000919574-24-003355#line-3","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18304.0,"shares_display":"18,304","price_per_share":20.6057,"price_display":"20.61","price_state":"stated","total_value":377166.7328,"total_display":"377,166.73","total_whole":"377,167","shares_owned_after":2923509.0,"shares_owned_after_display":"2,923,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-28","scope":"insider"},{"id":2500601,"accession":"0000919574-24-003355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-003355","line_url":"/filing/0000919574-24-003355#line-2","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":144196.0,"shares_display":"144,196","price_per_share":20.1178,"price_display":"20.12","price_state":"stated","total_value":2900906.2888,"total_display":"2,900,906.29","total_whole":"2,900,906","shares_owned_after":2905205.0,"shares_owned_after_display":"2,905,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-24","filed_date":"2024-05-28","scope":"insider"},{"id":2579704,"accession":"0000919574-24-003356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003356","line_url":"/filing/0000919574-24-003356#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners FO1-MSV, LP; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC","owner_display_name":"Casdin Partners FO1-MSV, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":260000.0,"total_display":"260,000.00","total_whole":"260,000","shares_owned_after":46075821.0,"shares_owned_after_display":"46,075,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-28","scope":"insider"},{"id":2500594,"accession":"0000919574-24-003355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003355","line_url":"/filing/0000919574-24-003355#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":19.5888,"price_display":"19.59","price_state":"stated","total_value":146916.0,"total_display":"146,916.00","total_whole":"146,916","shares_owned_after":2761009.0,"shares_owned_after_display":"2,761,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-28","scope":"insider"},{"id":2035282,"accession":"0000919574-24-003308","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-003308","line_url":"/filing/0000919574-24-003308#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.5849,"price_display":"2.58","price_state":"stated","total_value":387735.0,"total_display":"387,735.00","total_whole":"387,735","shares_owned_after":45975821.0,"shares_owned_after_display":"45,975,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-22","scope":"insider"},{"id":2035281,"accession":"0000919574-24-003308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-003308","line_url":"/filing/0000919574-24-003308#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":2.5598,"price_display":"2.56","price_state":"stated","total_value":895930.0,"total_display":"895,930.00","total_whole":"895,930","shares_owned_after":45825821.0,"shares_owned_after_display":"45,825,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider"},{"id":2035280,"accession":"0000919574-24-003308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003308","line_url":"/filing/0000919574-24-003308#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.5813,"price_display":"2.58","price_state":"stated","total_value":258130.0,"total_display":"258,130.00","total_whole":"258,130","shares_owned_after":45475821.0,"shares_owned_after_display":"45,475,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":2079554,"accession":"0000919574-24-003252","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-003252","line_url":"/filing/0000919574-24-003252#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund, L.P.","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":352072.0,"shares_display":"352,072","price_per_share":2.5621,"price_display":"2.56","price_state":"stated","total_value":902043.6712,"total_display":"902,043.67","total_whole":"902,044","shares_owned_after":45375821.0,"shares_owned_after_display":"45,375,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-17","scope":"insider"},{"id":2079549,"accession":"0000919574-24-003252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-003252","line_url":"/filing/0000919574-24-003252#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund, L.P.","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.5419,"price_display":"2.54","price_state":"stated","total_value":1270950.0,"total_display":"1,270,950.00","total_whole":"1,270,950","shares_owned_after":45023749.0,"shares_owned_after_display":"45,023,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":2079546,"accession":"0000919574-24-003252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003252","line_url":"/filing/0000919574-24-003252#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund, L.P.","owner_display_name":"Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.5651,"price_display":"2.57","price_state":"stated","total_value":1282550.0,"total_display":"1,282,550.00","total_whole":"1,282,550","shares_owned_after":44523749.0,"shares_owned_after_display":"44,523,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":2138832,"accession":"0000919574-24-003212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003212","line_url":"/filing/0000919574-24-003212#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":23.3059,"price_display":"23.31","price_state":"stated","total_value":1165295.0,"total_display":"1,165,295.00","total_whole":"1,165,295","shares_owned_after":2753509.0,"shares_owned_after_display":"2,753,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":2765157,"accession":"0000919574-24-001889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-001889","line_url":"/filing/0000919574-24-001889#line-2","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":8.827,"price_display":"8.83","price_state":"stated","total_value":7944.3,"total_display":"7,944.30","total_whole":"7,944","shares_owned_after":2703509.0,"shares_owned_after_display":"2,703,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2300357,"accession":"0000919574-24-001888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-001888","line_url":"/filing/0000919574-24-001888#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"Casdin Partners Master Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1403.0,"shares_display":"1,403","price_per_share":2.615,"price_display":"2.62","price_state":"stated","total_value":3668.845,"total_display":"3,668.84","total_whole":"3,669","shares_owned_after":11497928.0,"shares_owned_after_display":"11,497,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2765149,"accession":"0000919574-24-001889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-001889","line_url":"/filing/0000919574-24-001889#line-1","is_derivative":false,"issuer_cik":"0001534260","issuer_name":"GeneDx Holdings Corp.","issuer_ticker":"WGS","issuer_name_source":null,"issuer_url":"/issuer/0001534260","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.","owner_display_name":"Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":8.7427,"price_display":"8.74","price_state":"stated","total_value":349708.0,"total_display":"349,708.00","total_whole":"349,708","shares_owned_after":2702609.0,"shares_owned_after_display":"2,702,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":2300350,"accession":"0000919574-24-001888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-001888","line_url":"/filing/0000919574-24-001888#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Private Growth Equity Fund II, L.P.","owner_display_name":"Casdin Partners Master Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":642500.0,"total_display":"642,500.00","total_whole":"642,500","shares_owned_after":11496525.0,"shares_owned_after_display":"11,496,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8352302,"accession":"0000919574-23-003425","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-23-003425","line_url":"/filing/0000919574-23-003425#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":2.2949,"price_display":"2.29","price_state":"stated","total_value":1835920.0,"total_display":"1,835,920.00","total_whole":"1,835,920","shares_owned_after":1200000.0,"shares_owned_after_display":"1,200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-19","scope":"insider"},{"id":8352297,"accession":"0000919574-23-003425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-23-003425","line_url":"/filing/0000919574-23-003425#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.1591,"price_display":"2.16","price_state":"stated","total_value":323865.0,"total_display":"323,865.00","total_whole":"323,865","shares_owned_after":400000.0,"shares_owned_after_display":"400,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":8352290,"accession":"0000919574-23-003425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-23-003425","line_url":"/filing/0000919574-23-003425#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC","owner_display_name":"Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.8862,"price_display":"1.89","price_state":"stated","total_value":471550.0,"total_display":"471,550.00","total_whole":"471,550","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818331","name":"GeneDx Holdings Corp.","url":"/issuer/0001818331","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2024-03-06","last_seen":"2024-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001162194","name":"STANDARD BIOTOOLS INC.","url":"/issuer/0001162194","role":"Director","n_filings":5,"first_seen":"2023-05-19","last_seen":"2024-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001938709","retrieved_at":"2026-08-23T06:30:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}